A well-tolerated, inexpensive friendly bacterium with over a century of use. Its most credible benefits are modest: slightly lower cholesterol, fewer antibiotic-triggered loose stools, and support during stomach-ulcer treatment. Digestion, women's health, blood-sugar, and immune claims are weaker; slowing aging or sharpening the mind remains unproven. Safe for healthy people, risky mainly for the seriously immunocompromised. (Full Review)

Protocol

Standard Dose

1–10 billion CFU/day

Up to 20 billion+ for specific goals such as antibiotic co-therapy; strain identity matters more than raw count

Strain

NCFM or DDS-1

Defined strains dominate the clinical literature; unlabeled "acidophilus" may not match studied strains

Timing

With or before a meal

A little food and fat buffers stomach acid and improves survival; consistency matters more than the hour

Time to effect

Lipid / Metabolic

6–12 weeks

Sustained use needed to assess cholesterol and metabolic response

Digestive

Days–2 weeks

Tolerance and regularity changes appear early

Benefits

Medium: Lower total & LDL cholesterol; prevention of antibiotic-associated diarrhea; adjunct to H. pylori eradication

Low: IBS symptom relief; improved lactose digestion; vaginal & urogenital support; modest glycemic improvements; immune & respiratory support

Speculative: Healthy aging & reduced inflammaging; mood & cognitive support

Contraindications

Severe immunocompromise (transplant, neutropenic chemotherapy, advanced/untreated HIV)

Critical illness / intensive care

Central venous catheters or prosthetic heart valves

Short bowel syndrome

Acute pancreatitis

Very premature or critically ill infants (specialist supervision only)

Key Interactions

Antibiotics (amoxicillin, ciprofloxacin, clindamycin)

Antifungals (oral nystatin, fluconazole)

Immunosuppressants (tacrolimus, cyclosporine, prednisone, biologics)

Bile acid sequestrants (cholestyramine, colesevelam)

Antacids / proton-pump reducers (omeprazole, famotidine)

Prebiotic fibers & other probiotics (inulin, fructooligosaccharides)

Risk & Side Effects

High: Gas, bloating & transient digestive discomfort

Medium: Systemic infection in immunocompromised or critically ill; D-lactic acidosis & probiotic-related brain fog

Low: Allergic reactions & carrier/excipient sensitivity; symptom flare in bacterial overgrowth

Speculative: Transfer of antibiotic-resistance genes; histamine-related sensitivity

Monitoring

Marker	Target	Why
LDL cholesterol	< 100 mg/dL	Tracks the main measurable lipid benefit
Total cholesterol	< 180 mg/dL	Captures overall lipid response to bile-acid effects
Fasting glucose	70–90 mg/dL	Screens for the small, inconsistent metabolic effect
Hemoglobin A1c	< 5.4%	Reflects average blood sugar over ~3 months
hs-CRP	< 1.0 mg/L	Gauges systemic inflammation relevant to the aging hypothesis

Cadence: Reassess lipid or metabolic markers at 8–12 weeks, then every 6–12 months if used long-term; no routine monitoring for general digestive use

Qualitative Assessment

Bowel regularity and stool consistency
Bloating, gas, and abdominal comfort
Digestive tolerance of dairy or trigger foods
Frequency of minor infections (digestive, respiratory, urogenital)
Energy, mental clarity, and overall sense of wellbeing

Lactobacillus acidophilus for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment